“…Indeed, numerous association studies have linked BPA and analogs to human reproductive diseases and disorders including increased miscarriage rates ( Sugiura-Ogasawara et al, 2005 , Zbucka-Kretowska et al, 2018 ), low fetal birth weight ( Huo et al, 2015 ), birth defects such as male hypospadias ( Pallotti et al, 2020 ), endometriosis ( Buck Louis et al, 2013 , Simonelli et al, 2017 ), polycystic ovary syndrome ( Rutkowska and Rachon, 2014 ), breast and prostate cancer ( Jenkins et al, 2009 , Moral et al, 2008 , Shafei et al, 2018 , Zhang et al, 2014 ), and precocious puberty ( Leonardi et al, 2017 ), in addition to many neurological, immune, and metabolic disorders ( Robinson and Miller, 2015 , Kardas et al, 2016 , Thongkorn et al, 2019 , Li et al, 2018 , Tewar et al, 2016 , Legeay and Faure, 2017 , Wang et al, 2012 , Wang et al, 2019 , Yang et al, 2020 , Youssef et al, 2018 ). Further, several large studies have reported that in couples undergoing in vitro fertilization (IVF) there were significant correlations between higher urinary BPA concentrations and reduced sperm counts, and abnormal sperm motility and morphology in men, reduced oocyte yield and peak serum estradiol in women, and reduced success with IVF ( Joint and WHO, 2011 , Matuszczak et al, 2019 , Mok-Lin et al, 2010 ).…”